Healthcare of Ontario Pension Plan Trust Fund Sells 193,454 Shares of Neogen Corporation $NEOG

Posted by Brenda Bartman on Jul 27th, 2026

Healthcare of Ontario Pension Plan Trust Fund cut its holdings in Neogen Corporation (NASDAQ:NEOG – Free Report) by 5.5% during the 1st quarter, HoldingsChannel reports. The fund owned 3,297,346 shares of the company’s stock after selling 193,454 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Neogen were worth $30,632,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Cibc World Markets Corp bought a new stake in Neogen in the 4th quarter valued at about $47,983,000. T. Rowe Price Investment Management Inc. increased its holdings in shares of Neogen by 249.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company’s stock worth $57,191,000 after purchasing an additional 5,838,570 shares during the period. SG Americas Securities LLC increased its holdings in shares of Neogen by 287.4% during the first quarter. SG Americas Securities LLC now owns 6,266,033 shares of the company’s stock worth $58,211,000 after purchasing an additional 4,648,436 shares during the period. Bank of Montreal Can raised its position in shares of Neogen by 4,059.4% in the third quarter. Bank of Montreal Can now owns 4,592,218 shares of the company’s stock valued at $26,222,000 after buying an additional 4,481,812 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its position in shares of Neogen by 809.8% in the third quarter. BNP Paribas Financial Markets now owns 2,660,884 shares of the company’s stock valued at $15,194,000 after buying an additional 2,368,410 shares in the last quarter. 96.73% of the stock is owned by institutional investors.

Neogen Stock Performance

Shares of Neogen stock opened at $9.40 on Monday. The company has a current ratio of 3.92, a quick ratio of 2.84 and a debt-to-equity ratio of 0.38. The company has a market cap of $2.05 billion, a PE ratio of -3.36, a price-to-earnings-growth ratio of 4.21 and a beta of 1.80. The company has a 50 day moving average of $9.28 and a 200-day moving average of $9.57. Neogen Corporation has a 1-year low of $4.56 and a 1-year high of $11.43.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Weiss Ratings cut Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. Wall Street Zen upgraded Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Neogen presently has an average rating of “Hold” and a consensus price target of $10.67.

Read Our Latest Report on NEOG

Neogen Company Profile

(Free Report)

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.